Lumida
/SYRE
⌘K
Spyre Therapeutics Inc

Spyre Therapeutics Inc

SYRE
$90.60USD+2.13%+1.89 today

MARKET CAP

8.0B

P/E (TTM)

FWD P/E

DAY RANGE

$88 – $91

52W RANGE

$15
$110

AI Summary

Stalk
Sell NowMedium

SYRE has broken decisively below its 9-, 20-day EMAs and 50-day SMA, shifting into a corrective/distribution phase. Short-term momentum remains negative, with price extended below declining EMAs and oversold RSI triggering temporary relief risk but no sustained stabilization. Medium-term bias is firmly bearish, favoring execution on rallies into the dynamic resistance zone around the 97–100 EMA area. Sell Now is recommended to capture further downside with rejection at EMAs.

  • Multiple analysts maintain Buy ratings with $120–$140 targets
  • Launched SPY772 Phase 2 SKYLIGHT trial targeting Hidradenitis Suppurativa
  • Weak profitability factors highlight margin and return challenges
Full analysis →

Buying

9

institutions

Selling

6

institutions

New Positions

1

this quarter

Filing Period

Q1 2026

latest 13-F

13-F Holdings

InstitutionActionShares HeldValueChangeChg %Weight
BI

Blackrock, Inc.

Q2 2026

BUY6.51 M577.66 M+985.38 K+107.4%0.01%
PA

Perceptive Advisors LLC

Q2 2026

SELL4.32 M383.48 M+-3.25 M+0.5%5.77%
RI

Rtw Investments, LP

Q2 2026

BUY4.25 M377.49 M+80.00 K+79.4%3.22%
JH

Janus Henderson Group Plc

Q1 2026

BUY3.31 M167.17 M+1.48 M+179.0%0.04%
JC

Jpmorgan Chase & Co

Q2 2026

BUY1.09 M98.87 M+113.73 K+122.3%0.01%
WP

Woodline Partners LP

Q2 2026

SELL306.05 K27.17 M+-225.74 K+1.3%0.08%
AC

Adar1 Capital Management, LLC

Q2 2026

SELL283.98 K25.21 M+-54.34 K+47.7%1.16%
MM

Millennium Management LLC

Q2 2026

BUY196.71 K17.46 M+50.07 K+136.1%0.01%
CA

Citadel Advisors LLC

Q2 2026

BUY154.80 K13.74 M+31.36 K+120.7%0.00%
BA

Balyasny Asset Management L.P.

Q2 2026

BUY147.04 K13.05 M+91.56 K+366.5%0.02%
RC

Rockefeller Capital Management L.P.

Q2 2026

SELL47.47 K4.21 M+-16.54 K+30.5%0.01%
AC

Aqr Capital Management LLC

Q2 2026

BUY22.94 K2.04 M+2.06 K+93.4%0.00%
BH

Brevan Howard Capital Management LP

Q2 2026

BUYNEW8.29 K735.81 K+8.29 K+0.0%0.01%
MG

Man Group Plc

Q2 2026

SELL7.71 K684.85 K+-1.83 K+42.2%0.00%
RC

Ra Capital Management, L.P.

Q2 2026

SELL0.000.00+-1.62 M-100.0%0.00%